Comparison of the efficacy and safety of 160 mcg ciclesonide administered once daily in the evening with or without different spacer types in patients with asthma
Phase of Trial: Phase III
Latest Information Update: 02 Dec 2016
At a glance
- Drugs Ciclesonide (Primary)
- Indications Asthma
- Focus Registrational; Therapeutic Use
- Sponsors Takeda Global Research and Development Center
- 04 May 2012 Company (Takeda Global Research and Development Center) added as reported by ClinicalTrials.gov.
- 01 Nov 2009 Efficacy and tolerability results reported in Respiratory Medicine.
- 24 Dec 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History